Hyperthyroidism in pregnancy: diagnosis and treatment

Area of Science:

• Endocrinology
• Obstetrics & Gynecology
• Reproductive Medicine

Background:

• Autoimmune Graves' disease is the most common cause of hyperthyroidism in pregnant women.
• Hyperthyroidism affects approximately 2 in 1000 pregnancies.
• While menstrual irregularities are common, impaired fertility in mild to moderate hyperthyroidism lacks strong evidence.

Purpose of the Study:

• To review the symptomatology and diagnosis of hyperthyroidism in pregnancy.
• To discuss therapeutic options for pregnant women with hyperthyroidism.
• To explore controversies regarding maternal and fetal outcomes in pregnancies complicated by thyrotoxicosis.

Main Methods:

• Literature review focusing on hyperthyroidism in pregnancy.
• Synthesis of current knowledge on diagnosis and management.
• Analysis of existing data on maternal and fetal outcomes.

Main Results:

• Hyperthyroidism in pregnancy poses significant diagnostic and therapeutic challenges.
• Management strategies aim to balance maternal well-being and fetal health.
• Outcomes are influenced by disease severity and treatment efficacy.

Conclusions:

• Effective management of hyperthyroidism is crucial for successful pregnancy outcomes.
• Further research is needed to clarify controversies surrounding maternal and fetal outcomes.
• Multidisciplinary care is essential for optimizing patient care.